Global Pharmacogenetic Testing Market
According to Intent Market Research, the Pharmacogenetic Testing Market is expected to grow from USD 6.0 Billion in 2024-e at a CAGR of 10.0% to touch USD 10.6 Billion by 2030. The Pharmacogenetic Testing Market is dominated by key players such as 23andMe, Inc., Thermo Fisher Scientific Inc., Illumina, Inc., Laboratory Corporation of America Holdings (LabCorp), Invitae Corporation, and Quest Diagnostics Incorporated.